Biogen Inc
(BIIB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 0 | 0 | 21,470 | 0 | 0 |
| Depreciation Amortization | 0 | 0 | 4,270 | 0 | 0 |
| Other Working Capital | 0 | 0 | -20,910 | 0 | 0 |
| Other Operating Activity | 24,260 | 7,720 | 250 | -2,230 | 1,290 |
| Operating Cash Flow | $24,260 | $7,720 | $5,080 | $-2,230 | $1,290 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,530 | -610 | -1,720 | -1,250 | -630 |
| Other Investing Activity | -98,750 | -48,840 | -11,820 | -11,400 | -3,940 |
| Investing Cash Flow | $-100,280 | $-49,450 | $-13,540 | $-12,650 | $-4,570 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 117,580 | 115,640 | 530 | -900 | 240 |
| Financing Cash Flow | $117,580 | $115,640 | $530 | $-900 | $240 |
| Beginning Cash Position | 26,920 | 26,920 | 34,840 | 34,840 | 34,840 |
| End Cash Position | 68,500 | 100,840 | 26,920 | 19,040 | 31,810 |
| Net Cash Flow | $41,570 | $73,910 | $-7,910 | $-15,800 | $-3,030 |
| Free Cash Flow | |||||
| Operating Cash Flow | 24,260 | 7,720 | 5,080 | -2,230 | 1,290 |
| Free Cash Flow | 24,260 | 7,720 | 5,080 | -2,230 | 1,290 |